A patent infringement suit filed by King Pharmaceuticals, Inc. and Elan Pharma International Ltd. against Actavis, Inc. relating to Avinza (morphine sulfate) was settled in July 2011. The Company acquired…
Patent infringement suits filed by Wyeth and Nycomed GmbH against Teva USA and Teva Pharmaceutical Industries, Sun Pharmaceutical Advanced Research Centre Ltd. and Sun Pharmaceutical Industries Ltd. relating to Protonix…
Patent infringement suits filed by Abbott Laboratories against Impax Laboratories and Teva Pharmaceuticals USA Inc. relating to Tricor(R) were settled and dismissed with prejudice during the second quarter of 2011.
In…
A trial in a trademark infringement suit filed by Sharp Corporation against Dell Inc. is scheduled this month.
Sharp filed a suit against Dell in October 2008 for trademark infringement, unfair…
Patent infringement suits filed by Johnson & Johnson, Inc., Cordis Corporation, a wholly owned subsidiary of Johnson & Johnson, and Wyeth against Abbott Laboratories related to Xience V stent remain…
Abbott Laboratories’ patent infringement suits against various companies relating to Tricor(R) remain pending.
Abbott is seeking to enforce its patent rights relating to fenofibrate tablets (a drug Abbott sells under the…
Gilead Sciences Inc.’s patent infringement suit against Lupin Limited relating to Ranexa is pending.
In June 2010, the Company received notice that Lupin submitted an ANDA to the FDA requesting permission…
Merck & Co. Inc.’s patent infringement suit against Mylan Pharmaceuticals, Inc. relating to Zetia remains pending.
In May 2010, Schering Corp. received notice from Mylan Pharmaceuticals, Inc. that it filed an…
A decision in Merck & Co. Inc.’s lawsuit seeking a prohibition order against the approval of Teva Pharmaceuticals, Inc application to sell the Company generic ezetimibe prior to the September…
Merck & Co. Inc.’s patent infringement suit against Teva Pharmaceuticals, Inc. relating to ezetimibe/simvastatin is pending.
In February 2010, Schering Corp. received notice from Teva that it filed an ANDA for…